Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer's Disease | ACS Omega
Decreased salivary lactoferrin levels are specific to Alzheimer's disease - eBioMedicine
JPM | Free Full-Text | Biomarkers for Alzheimer's Disease Early Diagnosis
IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment
Structural Dynamics of Amyloid-β Protofibrils and Actions of Anti-Amyloid-β Antibodies as Observed by High-Speed Atomic Force Microscopy | Nano Letters
Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future | Signal Transduction and Targeted Therapy
Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients
Frontiers | Alzheimer's disease: a mini-review for the clinician
Cells | Free Full-Text | Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
ADPD 2023: Alzheimer's Disease Therapeutics, Diagnostics & Mechanisms
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics
An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments | Cell Research
JCM | Free Full-Text | Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment
Nasal administration of anti-CD3 monoclonal antibody ameliorates disease in a mouse model of Alzheimer's disease | PNAS
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review - ScienceDirect
Pyroglutamate Aβ cascade as drug target in Alzheimer's disease | Molecular Psychiatry
Advances in the development of new biomarkers for Alzheimer's disease | Translational Neurodegeneration | Full Text
Identifying and validating biomarkers for Alzheimer's disease: Trends in Biotechnology
Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice - The Journal of Nutrition
Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia | ACS Chemical Neuroscience
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD - Tramutola - 2015 -
Blood‐based biomarkers for Alzheimer's disease | EMBO Molecular Medicine
The Amyloid-β Pathway in Alzheimer's Disease | Molecular Psychiatry
Amyloid blood biomarker detects Alzheimer's disease | EMBO Molecular Medicine
